Cannabidiol May Be Effective Adjunct to Antipsychotic Treatment for Schizophrenia Patients

Patients with schizophrenia who are prescribed cannabidiol (CBD) in
addition to antipsychotics may experience lower levels of positive
psychotic symptoms compared with those taking antipsychotics
alone, according to a report in AJP in Advance.

READ MORE

Folate, Vitamin D Found Lower in People Who Have Experienced First-Episode Psychosis

Patients who have experienced first-episode psychosis (FEP)
appear to have significantly lower levels of folate and
vitamin D in their blood compared with individuals with no
psychiatric diagnosis, according to a report in Schizophrenia
Bulletin.

READ MORE

Rise in Antidepressant Prescriptions for Youth Raises Questions About Why

The number of prescriptions of antidepressants for children
and adolescents fell after the Food and Drug Administration
in 2004 directed pharmaceutical companies to issue a blackbox
warning about the potential link between antidepressant
use and the risk of increased suicidal ideation among youth.

READ MORE

TREATABLE IMMUNE SYSTEM DISORDER COULD BE MISTAKEN FOR SCHIZOPHRENIA OR BIPOLAR DISORDER

A major finding from researchers at Houston Methodist reveals a significant number of people diagnosed with schizophrenia or bipolar disorder may actually have a treatable immune system disorder. The condition causes NMDA receptors to stop functioning properly and can result in symptoms commonly associated with neuropsychiatric disorders.

READ MORE

Genome-Wide Studies Aid Investigation of Dual Diagnosis of Schizophrenia and Substance Use Disorder

Several new genome-wide investigations of schizophrenia and substance-use disorders are helping researchers understand how these two conditions may be related, according to a paper published in Genome Medicine.

READ MORE

Research findings will help identify genetic causes of brain disorders

New findings will help to identify the genetic causes of brain disorders: researchers at the Universities of Basel, Bonn and Cologne have presented a systematic catalog of specific variable locations in the genome that influence gene activity in the human hippocampus, as they report in the journal Nature Communications.

READ MORE